Humacyte Securities Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Humacyte · Humacyte securities · Ongoing Litigation
Last updated
About this case
Humacyte and certain executives were sued in a securities class action alleging that they failed to disclose material information about the company’s FDA review and manufacturing operations, in violation of federal securities laws. The litigation remains ongoing.
Case overview
- Defendant company
- Humacyte
- Product or service
- Humacyte securities
- Court case number
- 1:24-cv-00954
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Participation information
Availability is based on each listed participation option and its deadline.
Kahn Swick & Foti investigation inquiry
The law firm invites Humacyte shareholders or people with relevant information to contact it regarding its investigation.
Contact Kahn Swick & Foti by phone or email, or use the firm’s online inquiry page.
- Type
- Law Firm Signup
- Status
- Unknown
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Humacyte Securities Class Action
Barchart.com ·